Send an Enquiry

Cortechs.a
NeuroQuant Brain Tumor

Request a Demo
Olea Medical-Cardiology, Kryptonite solutions
NeuroQuant® Brain Tumor
FDA-cleared software for advanced brain tumor analyses

Powered by AI and advanced diffusion MRI, NeuroQuant® Brain Tumor assists radiologists, oncologists, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.

Automated Brain Tumor Segmentation

NeuroQuant® Brain Tumor includes tumor segmentations that are color-coded slice by slice and routed to PACS, making it easy for radiologists to identify regions of interest and track changes over time. The integration of Restriction Spectrum Imaging (RSI) provides deeper insights into tumor microstructure, enhancing the analysis with more detailed information than traditional imaging methods.

Olea Medical-Cardiology, Kryptonite solutions
Olea Medical-Cardiology, Kryptonite solutions
OnQ™ Prostate Next-Level Prostate Imaging

OnQ Prostate is an FDA-cleared software solution using Restriction Spectrum Imaging (RSI), a patented diffusion MRI method that has been shown to improve detection, in vivo characterization, and localization of clinically significant cancer.

Improved accuracy for quality reads

Through clear, easy-to-interpret images OnQ™ Prostate empowers collaborative decision-making and enhances targeting for biopsy and therapy. Elevating clinical workflows that use MRI for prostate cancer detection, monitoring, and treatment, it helps bridge the gaps between radiologists and referring physicians.

Olea Medical-Cardiology, Kryptonite solutions
Benefits
Change visualization

Use high-resolution 3D T1 images to detect subtle changes in ventricle expansion, tissue atrophy, and swelling.

Longitudinal disease tracking

Monitor structure volumes and visually evaluate changes using color-coded overlays and change quantification data.

Normative reference data

Compare the patient’s brain structure volume measurements to a normal population.

Accuracy across all ages

Analyze ages 3-100 using our Dynamic Atlas™ technology, validated over thousands of clinical cases.

Adaptable data outputs

Tailor solutions for a broad spectrum of neurological disorders, including white matter hyperintensities for Alzheimer’s disease.

Color-coded lesion segmentation

Identify confluent lesions and new lesion load

Track progression over time

Longitudinal reporting monitors structure volumes and visual changes from previous scans – all within a single report.

Change visualization

Color-coded overlay demonstrates lesion dynamics.

Normative reference data

Compare the patient’s brain structure volume measurements to a normal population.

Accuracy across all ages

Analyse ages 3-100 using our Dynamic Atlas™ technology, validated over thousands of clinical cases.


©2024 Kryptonite SolutionsTM. All Rights Reserved.


Powered by: Purple Tuché